<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Statosphere: Diabetes Risk score</title>
    <meta charset="utf-8" />
    <script src="index_files/header-attrs-2.18/header-attrs.js"></script>
    <link href="index_files/remark-css-0.0.1/default.css" rel="stylesheet" />
    <script src="index_files/htmlwidgets-1.5.4/htmlwidgets.js"></script>
    <script src="index_files/viz-1.8.2/viz.js"></script>
    <link href="index_files/DiagrammeR-styles-0.2/styles.css" rel="stylesheet" />
    <script src="index_files/grViz-binding-1.0.9/grViz.js"></script>
    <script type="text/x-mathjax-config">
      MathJax.Hub.Config({
        TeX: { equationNumbers: { autoNumber: "AMS" } },
      });
    </script>
    <style>
    .mjx-mrow a {
      color: black;
      pointer-events: none;
      cursor: default;
    }
    </style>
    <link rel="stylesheet" href="assets/sydney-fonts.css" type="text/css" />
    <link rel="stylesheet" href="assets/sydney.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">




class: title-slide
background-image: url("assets/title-image2.jpg")
background-position:  100% 50%
background-size: 100% 100%

# .text-shadow[.black[Predicting diabetes in Australian males at high risk]]
&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;
### .text-shadow[.white[&lt;br&gt;&lt;br&gt;&lt;br&gt; &amp;nbsp;Dr Kristy Robledo &lt;br&gt; &lt;svg viewBox="0 0 512 512" style="height:1em;position:relative;display:inline-block;top:.1em;fill:blue;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"&gt;&lt;/path&gt;&lt;/svg&gt; @kristyrobledo]]
---

.pull-left-1[
  .center[
&lt;img src="assets/Diabetes-infographic-part1.jpg" height=630&gt;
]
]

--
.pull-right-2[

  .center[
&lt;img src="assets/riskscore.JPG" height=450&gt;
]


.font60[
Courtesy: [World health Organisation](https://www.who.int/news-room/fact-sheets/detail/diabetes) and

Diabetes Australia Risk score calculator developed by Baker IDI Heart Diabetes Institute. [https://www.diabetesaustralia.com.au/risk-calculator/](https://www.diabetesaustralia.com.au/risk-calculator/)
]
]



???

---

# .brand-red[Development cohort: T4DM trial]

.pull-left-1[

.content-box-yellow[

- males aged 50 to 74 years, 
- waist circumference ≥95 cm, 
- impaired glucose tolerance or newly diagnosed type 2 diabetes,
- fasting testosterone ≤14 nmol/L

]
&lt;br&gt;

.content-box-grey[
.blue[**Primary outcome:**] Diabetes at two years, as measured by 2-hour glucose by OGTT `\(\ge\)` 11.1mmol/L
]
]
???
Prognostic model development: 807 males without baseline diabetes randomised to placebo or testosterone treatment in the T4DM study

Diabetes at two years, defined as 2-hour fasting glucose by oral glucose tolerance test (OGTT) greater than or equal to 11.1mmol/L.

--

.pull-right-2[
 .center[
  &lt;img src="assets/short_flow.png" height=500&gt;
]

]

.footnote[
Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): A randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. The Lancet Diabetes &amp; Endocrinology 2021;9:32–45. [https://doi.org/10.1016/S2213-8587(20)30367-3](https://doi.org/10.1016/S2213-8587(20)30367-3)
]
---
class: center



background-image: url("wordcloud.png")
background-position:  50% 50%
background-size: 90% 90%

# .brand-red[35 risk factors]

---

# .brand-red[Step one: select risk factors + fit model]

.pull-left-1[
.content-box-yellow[
- LASSO penalisation.fn[1] using 469 with complete data
- 10 fold cross validation was used to maximise AUC
- dotted line denotes max AUC, with two non-zero covariates selected in the model (HbA1c and 2-hour glucose)
- refit without penalisation, with AUC **0.809** (n= 665 patients)
- including T treatment.fn[2], AUC **0.816**.
]
]

.pull-right-2[
.center[
  &lt;img src="assets/lasso_cv.png" height=500&gt;
]
]

.footnote[
1. Zhao S, Daniela Witten, Ali Shojaie "In Defense of the Indefensible: A Very Naïve Approach to High-Dimensional Inference," Statistical Science. 36(4), 562-577, (November 2021) [https://doi.org/10.1214/20-STS815](https://doi.org/10.1214/20-STS815)
1. **T treatment was associated with 40% reduction in diabetes at two years**
]



???
Least absolute shrinkage and selection operator (LASSO) penalisation was performed to select risk factors, prevent over-fitting, and reduce the dimensions of the prediction model [12]. To determine the penalty factor (λ), tenfold cross validation was performed, to maximise the area under the curve (AUC).

---

# .brand-red[Step two: Validation]

.pull-left[
.content-box-yellow[
.font120[
- EXTEND45 cohort of 267,357 participants aged 45 and up
- conduct approved by the University of New South Wales HREC
- baseline questionnaires collected Jan 2006 - Dec 2009
- lab data linked up to July 2013
]
]
]
--

.pull-right[
<div id="htmlwidget-c0444eb54930dae64a3c" style="width:95%;height:500px;" class="grViz html-widget"></div>
<script type="application/json" data-for="htmlwidget-c0444eb54930dae64a3c">{"x":{"diagram":"digraph {\n  graph [layout = dot, rankdir = TB]\n  \n  node [shape = rectangle]        \n  rec1 [label = \"HbA1c and 2-hour glucose within 6 months (baseline, n=2026)\"]\n  rec2 [label = \"baseline 2-hour glucose <11.1mmol/L & HbA1c<6.5 (n=1189)\"]\n  rec3 [label =  \"outcome 2-hour glucose identified 1-4yr post baseline (n=452)\"]\n  rec4 [label = \"restrict to males (n=221)\"]\n  \n  # edge definitions with the node IDs\n  rec1 -> rec2 -> rec3 -> rec4\n  }","config":{"engine":"dot","options":null}},"evals":[],"jsHooks":[]}</script>

]

---

# .brand-red[Step three: Model performance (.bold[Discrimination])]

.center[
  &lt;img src="assets/ROC.png" height=540&gt;
]

???
T4DM AUC 0.820 (95% CI: 0.762-0.877) model has high discriminating ability.
extend45 - 0.806 (95% CI: 0.735-0.877). 

---
# .brand-red[Step three: Model performance (.bold[Calibration])]

.center[
  &lt;img src="assets/calibration.png" height=600&gt;
]


???
Risk groups: 25%, middle 50%, top 25% of risk
A comparison of the predicted probability versus the observed probability for each risk group is shown in Figure, demonstrating that there is a higher probability observed than predicted in the model validation cohort.

Calibration - T4DM
The Brier score was low at 0.07, the Hosmer–Lemeshow χ^2 statistic was 3.92, (p=0.86), and the p-value for the Osius-Rojek and Stukel tests were 0.71 and 0.04 respectively, indicating good calibration within the model development cohort, other than the Stukel test.

Extend45
The calibration according to the Hosmer-Lemeshow goodness of fit test was poor (χ^2=106, p&lt;0.001). However the Brier score for assessing prediction accuracy was low at 0.13 and the p-value for the Stukel test was 0.62, indicating a good fit, while the p-value for the Osius-Rojek test was p&lt;0.001. 

---
# .brand-red[Step four: Model performance (.bold[Recalibration])]

.center[
&lt;br&gt;
  &lt;img src="assets/recalibration.png" height=520&gt;
]

???
Given this under-prediction, recalibration in the large was performed and the intercept was estimated as 0.67. Once this was taken into account, the predicted probabilities from the model showed better alignment with the observed probabilities 
---
class: sydney-blue

# **Take home messages**

.font130[
- Risk score has been developed for Australian high risk men
]
--
.font130[
- 2-hour glucose by OGTT and Hb1ac are important risk factors
]
--
.font130[
- calibration in an opportunistic validation cohort gave some underestimation of risk (probably due to lifestyle component of T4DM)
]
--
.font130[
- high risk men not developing diabetes is likely due to changes in body composition over the trial
]
--
.font130[
- Future work: Shiny app for calculation of risk groups and **Publication**
]

???
OGTT is not a fun test

---
class: sydney-red
background-image: url(assets/USydLogo-white.svg),url(https://upload.wikimedia.org/wikipedia/commons/b/be/Sharingan_triple.svg)
background-size: 260px,100px
background-position: 5% 95%,4% 70%

# Thanks!

.pull-right-2[
.pull-up[
- Centre for Health Record Linkage (CHeReL), [http://www.cherel.org.au/](http://www.cherel.org.au/) for data linkage
- Secure Unified Research Environment (SURE) for provision of secure data access
- Participants of the T4DM trial and EXTEND45 cohort study
- co-authors, particularly Prof Gary Wittert and Prof Ian Marschner 
]

.pull-down[

&lt;a href="mailto:kristy.robledo@sydney.edu.au"&gt;
.white[&lt;svg viewBox="0 0 512 512" style="height:1em;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M440 6.5L24 246.4c-34.4 19.9-31.1 70.8 5.7 85.9L144 379.6V464c0 46.4 59.2 65.5 86.6 28.6l43.8-59.1 111.9 46.2c5.9 2.4 12.1 3.6 18.3 3.6 8.2 0 16.3-2.1 23.6-6.2 12.8-7.2 21.6-20 23.9-34.5l59.4-387.2c6.1-40.1-36.9-68.8-71.5-48.9zM192 464v-64.6l36.6 15.1L192 464zm212.6-28.7l-153.8-63.5L391 169.5c10.7-15.5-9.5-33.5-23.7-21.2L155.8 332.6 48 288 464 48l-59.4 387.3z"&gt;&lt;/path&gt;&lt;/svg&gt; kristy.robledo@sydney.edu.au]
&lt;/a&gt;

&lt;a href="https://kristyrobledo.github.io/riskscore_talk/"&gt;
.white[&lt;svg viewBox="0 0 512 512" style="height:1em;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M326.612 185.391c59.747 59.809 58.927 155.698.36 214.59-.11.12-.24.25-.36.37l-67.2 67.2c-59.27 59.27-155.699 59.262-214.96 0-59.27-59.26-59.27-155.7 0-214.96l37.106-37.106c9.84-9.84 26.786-3.3 27.294 10.606.648 17.722 3.826 35.527 9.69 52.721 1.986 5.822.567 12.262-3.783 16.612l-13.087 13.087c-28.026 28.026-28.905 73.66-1.155 101.96 28.024 28.579 74.086 28.749 102.325.51l67.2-67.19c28.191-28.191 28.073-73.757 0-101.83-3.701-3.694-7.429-6.564-10.341-8.569a16.037 16.037 0 0 1-6.947-12.606c-.396-10.567 3.348-21.456 11.698-29.806l21.054-21.055c5.521-5.521 14.182-6.199 20.584-1.731a152.482 152.482 0 0 1 20.522 17.197zM467.547 44.449c-59.261-59.262-155.69-59.27-214.96 0l-67.2 67.2c-.12.12-.25.25-.36.37-58.566 58.892-59.387 154.781.36 214.59a152.454 152.454 0 0 0 20.521 17.196c6.402 4.468 15.064 3.789 20.584-1.731l21.054-21.055c8.35-8.35 12.094-19.239 11.698-29.806a16.037 16.037 0 0 0-6.947-12.606c-2.912-2.005-6.64-4.875-10.341-8.569-28.073-28.073-28.191-73.639 0-101.83l67.2-67.19c28.239-28.239 74.3-28.069 102.325.51 27.75 28.3 26.872 73.934-1.155 101.96l-13.087 13.087c-4.35 4.35-5.769 10.79-3.783 16.612 5.864 17.194 9.042 34.999 9.69 52.721.509 13.906 17.454 20.446 27.294 10.606l37.106-37.106c59.271-59.259 59.271-155.699.001-214.959z"&gt;&lt;/path&gt;&lt;/svg&gt; kristyrobledo.github.io/riskscore_talk/]
&lt;/a&gt;

&lt;a href="http://twitter.com/kristyrobledo"&gt;
.white[&lt;svg viewBox="0 0 512 512" style="height:1em;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"&gt;&lt;/path&gt;&lt;/svg&gt; @kristyrobledo]
&lt;/a&gt;

&lt;a href="http://github.com/kristyrobledo"&gt;
.white[&lt;svg viewBox="0 0 496 512" style="height:1em;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"&gt;&lt;/path&gt;&lt;/svg&gt; @kristyrobledo]
&lt;/a&gt;

]]

???
sharingan
---
class: sydney-yellow

# Extras:  checks and more checks 

1. check relationships of continuous data and outcome

--

2. Account for missing data by assuming missing outcome is no diabetes

--

3. Check for inclusion of any non-zero covariates :

  - Best addition of age gave AUC .bold[0.830] (minor increase from 0.816)

--

3. Check for interactions

--

.center[
.content-box-grey[

BINGO: HbA1c and treatment

]
]

???
Given that 469 participants had all risk factors and outcome data available, a sensitivity analysis was performed assuming all patients with missing outcome data were not diabetic at two years. This gave a total of 539 patients available to perform logistic regression with LASSO (extra 70 patients) to identify the optimal λ and therefore the optimum risk factors in the model (step one). The previous model of HbA1c and 2-hour glucose by OGTT was within one standard error of the optimal λ, which is considered the most parsimonious model with the consideration of many risk factors (reference). 

    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script src="assets/remark-zoom.js"></script>
<script src="https://platform.twitter.com/widgets.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"ratio": "16:9",
"navigation": {
"scroll": false
}
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
// add `data-at-shortcutkeys` attribute to <body> to resolve conflicts with JAWS
// screen reader (see PR #262)
(function(d) {
  let res = {};
  d.querySelectorAll('.remark-help-content table tr').forEach(tr => {
    const t = tr.querySelector('td:nth-child(2)').innerText;
    tr.querySelectorAll('td:first-child .key').forEach(key => {
      const k = key.innerText;
      if (/^[a-z]$/.test(k)) res[k] = t;  // must be a single letter (key)
    });
  });
  d.body.setAttribute('data-at-shortcutkeys', JSON.stringify(res));
})(document);
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
